T Cell News and Research

Latest T Cell News and Research

Tips for parents to protect teens from summer injuries

Summer is the season of backyard barbecues, scenic drives through the countryside and heat-easing dips in the pool. For all of its fun, though, summer is also the time when you're most likely to suffer an injury, especially if you're a teenager, said trauma surgeon Dr. Thomas Esposito of Loyola University Health System in Maywood, Ill.

17 Jun 2011

Key to remove stem cells responsible for fat expansion

Researchers may have found the key to developing a method to rid the body of stem cells responsible for driving fat expansion. According to a report in the June 16 Cell Stem Cell, a Cell Press publication, they've landed the first protein marker on the surface of those so-called adipose stromal cells (ASCs), which serve as progenitors of the cells that make up fat tissue.

17 Jun 2011

New weapon in the fight against cancer

A cancer diagnosis is not necessarily a death sentence. There are now quite a number of possibilities to treat cancer. In addition to radiotherapy and chemotherapy, so-called radionuclide treatment has also become an important component in the fight against the mutated cells. It involves injecting radioactive elements, so-called nuclides, into the patient's circulatory system.

17 Jun 2011

Cedars-Sinai receives National Eye Institute grant to develop gene therapy for corneal disease

Cedars-Sinai stem cell researchers investigating ways to prevent eye problems in diabetic patients have been awarded a $3 million grant from the National Eye Institute to develop gene therapy in corneal stem cells to alleviate damage to corneas that can cause vision loss.

17 Jun 2011

New Australian drug shows positive response in patients with multiple myeloma blood cancer

Australian monoclonal antibody company, Immune System Therapeutics Limited (IST), today announced it would double patient recruitment in its Phase II trial for a breakthrough antibody treatment for terminal blood cancer.

16 Jun 2011

CEVEC and Catalent Pharma Solutions offer joint cell line development service

CEVEC Pharmaceuticals, the German developer of a novel, market leading human protein expression system derived from amniocytes, and Catalent Pharma Solutions, a leading global drug development and delivery solutions provider, announced today a joint commercial cell line development service for pharma and biotech customers worldwide. The offering combines the benefits of CEVEC’s human cell line, CAP-Technology, with Catalent’s unique GPEx® (Gene Product Expression) Technology to generate high expressing stable human cell lines in a much shorter timeframe than traditional methods.

16 Jun 2011

Hopkins research suggests that blood vessels and support cells may be real targets of treatment for diabetic nerve damage

Blood vessels and supporting cells appear to be pivotal partners in repairing nerves ravaged by diabetic neuropathy, and nurturing their partnership with nerve cells might make the difference between success and failure in experimental efforts to regrow damaged nerves, Johns Hopkins researchers report in a new study.

16 Jun 2011

Adaptimmune melanoma trial opening

Adaptimmune announced today that it has opened a Phase I/II, two cohort, open label clinical trial in metastatic melanoma at Washington University, St. Louis, Missouri.

16 Jun 2011

Researchers reveal why anti-androgen therapy may fail in men with prostate cancer

Cancer is crafty. When one avenue driving its growth is blocked by drugs targeting that path, the malignancy often creates a detour, finding an alternative route to get around the roadblock.

16 Jun 2011

Positive results from BiondVax Multimeric-001 Phase IIa trial against influenza

BiondVax Pharmaceuticals Ltd. today announced positive results from its first Phase II clinical trial of the Multimeric-001 Universal Influenza Vaccine.

16 Jun 2011

Initial data from COMPLETE study on peripheral T-cell lymphoma presented at ICML 2011

Allos Therapeutics, Inc. today announced the presentation of initial data from COMPLETE, an international registry designed to address the urgent need for an increased understanding of the treatment patterns and outcomes for patients with peripheral T-cell lymphoma.

16 Jun 2011

Lund University professor receives Robert A. Pritzker Prize for Parkinson's research

Anders Björklund from Lund University in Sweden has been awarded the Robert A. Pritzker Prize for his many years of leadership in research on Parkinson's disease. The prize has long been an institution in American architecture and this year, for the first time, it is also being awarded to recognise cutting-edge medical research.

16 Jun 2011

UCLA researchers find new potential therapeutic target for preventing HIV

Specific types of "helper" T cells that are crucial to maintaining functioning immune systems contain an enzyme called PDI. This enzyme affects how proteins fold into specific shapes, which in turn influences how the T cells behave.

16 Jun 2011

'Cell membrane capsules' made from real living cells improve functional drug delivery

The quest for better ways of encapsulating medicine so that it can reach diseased parts of the body has led scientists to harness - for the first time - living human cells to produce natural capsules with channels for releasing drugs and diagnostic agents.

16 Jun 2011

Stem cell technology corrects genetic defect in rare blinding disorder

Researchers have used cutting-edge stem cell technology to correct a genetic defect present in a rare blinding disorder, another step on a promising path that may one day lead to therapies to reverse blindness caused by common retinal diseases such as macular degeneration and retinitis pigmentosa which affect millions of individuals.

16 Jun 2011

Seattle Genetics brentuximab vedotin, dacetuzumab clinical data to be presented at ICML 2011

Seattle Genetics, Inc. today announced that data from its brentuximab vedotin and dacetuzumab programs will be presented at the 11th International Conference on Malignant Lymphoma being held June 15-18, 2011 in Lugano, Switzerland.

16 Jun 2011

Platelet Derived Growth Factor Receptor-beta plays key role in onset of obesity

A new study from Mount Sinai School of Medicine has found that a cellular signaling pathway governs the differentiation of cells into fat tissue or smooth muscle, which lines the vascular system. Engaging this signaling pathway and its capacity to govern cell differentiation has important implications in preventing obesity and cardiovascular disease.

16 Jun 2011

ISCO discovers novel technology to produce pure hepatocyte population

International Stem Cell Corporation announces the discovery of a novel, patent-pending technology to produce unlimited numbers of liver cells (hepatocytes) that are free of contamination with potentially dangerous undifferentiated cells.

16 Jun 2011

InNexus files patent protection for new Age-related Macular Degeneration therapeutic

InNexus Biotechnology Inc., a biopharmaceutical company creating and developing innovative solutions for cancer, inflammation and other difficult-to-treat diseases, announced today that it has filed for patent protection covering a novel antibody product for Age-related Macular Degeneration (AMD) and other eye disorders.

16 Jun 2011

ISSCR honors UCSF cancer scientist with 2011 Outstanding Young Investigator Award

UCSF's Robert Blelloch, MD, PhD, has received the 2011 Outstanding Young Investigator Award from the International Society for Stem Cell Research, for his pioneering research on the role of molecular tools known as microRNAs in embryonic stem cells and cancer.

16 Jun 2011

T Cell News and Research

Latest T Cell News and Research

Tips for parents to protect teens from summer injuries

Key to remove stem cells responsible for fat expansion

New weapon in the fight against cancer

Cedars-Sinai receives National Eye Institute grant to develop gene therapy for corneal disease

New Australian drug shows positive response in patients with multiple myeloma blood cancer

CEVEC and Catalent Pharma Solutions offer joint cell line development service

Hopkins research suggests that blood vessels and support cells may be real targets of treatment for diabetic nerve damage

Adaptimmune melanoma trial opening

Researchers reveal why anti-androgen therapy may fail in men with prostate cancer

Positive results from BiondVax Multimeric-001 Phase IIa trial against influenza

Initial data from COMPLETE study on peripheral T-cell lymphoma presented at ICML 2011

Lund University professor receives Robert A. Pritzker Prize for Parkinson's research

UCLA researchers find new potential therapeutic target for preventing HIV

'Cell membrane capsules' made from real living cells improve functional drug delivery

Stem cell technology corrects genetic defect in rare blinding disorder

Seattle Genetics brentuximab vedotin, dacetuzumab clinical data to be presented at ICML 2011

Platelet Derived Growth Factor Receptor-beta plays key role in onset of obesity

ISCO discovers novel technology to produce pure hepatocyte population

InNexus files patent protection for new Age-related Macular Degeneration therapeutic

ISSCR honors UCSF cancer scientist with 2011 Outstanding Young Investigator Award

Immunology eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

T Cell News and Research

Latest T Cell News and Research

Immunology eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in